Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations.
High-dose radiation, younger age increase risk of developing subsequent cancer, new study finds
Nancy Davidson, MD, on improving outcomes for women with breast, lung and colorectal cancer
‘To have your life-threatening cancer cured, and then to die of not being able to breathe? It’s devastating.’
The CASSINI Trial could inform new guidelines for diagnosing, preventing and treating cancer patients at high risk of developing blood clots
‘Patients are willing to participate in trials if they’re offered one.’
David MacPherson, PhD, discusses the state of SCLC research, how his lab is tackling the disease and what makes him excited for the future.
Once unheard-of survival rates seen among patients with advanced Merkel cell carcinoma.
Study reveals how blood vessels in the bone marrow protect dormant tumor cells, suggests a way to kill them in their sleep.
Loosening strict comorbidity criteria would open trials to thousands of previously ineligible patients.
New tech is giving scientists unprecedented insights into single cells’ inner workings.
Q&A: Riki Peters, PhD, MPH, on what this large genome-wide association study means for patients and the public
One hundred twenty volunteers to enroll in Seattle-area study of cancer-related gene mutations
First-in-human pilot of experimental immunotherapy in Merkel cell carcinoma
Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease.
Ten HIV-positive cancer patients to receive donated cord blood with rare resistance gene.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.